Jenna Norton, a program director at the National Institute for Diabetes and Digestive and Kidney Diseases, was ordered back to her NIH post on Friday after a month‑long paid leave. Norton had been sidelined in November when she returned from the 43‑day shutdown, then filed a whistle‑blower complaint alleging retaliation for co‑authoring the “Bethesda Declaration,” a June 2025 letter signed by roughly 500 NIH staff criticizing the Trump administration’s cuts to medical research.

The agency justified the leave by citing possible violations of the Antideficiency Act and internal communications rules, arguing that Norton, not a tenured researcher, lacked “academic freedom” to speak publicly. NIH director Jay Bhattacharya echoed those concerns, but lawyer Debra S. Katz countered that the Bethesda Declaration is protected First Amendment speech, and a pending lawsuit has left the department with little defensible ground.

Reinstatement follows a similar reversal for 14 FEMA employees who signed the “Katrina Declaration,” warning the agency of repeating past disaster‑response failures. Restoring Norton signals that officials may be wary of further litigation over whistle‑blower protections, yet her comment that the job “doesn’t really exist anymore” hints at lingering uncertainty for research programs stripped of diversity, equity and inclusion funding under the 2021 executive order.